Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL

Cellular therapies have transformed the treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL), which typically does not respond well to salvage chemotherapy.Recently, approximately 40% of r/r DLBCL patients across three different trials achieved a complete remission at 1 year after receiving treatment with autologous chimeric a

read more

Release Our Hostages Now!

It has been the policy of Rambam Maimonides Medical Journal to limit the number of editorials published.However, silence and standing on the sidelines is not an option in Books light of the atrocities and inhumanity we witnessed on October 7.The savagery of the Hamas massacre was executed indiscriminately upon children, women, older people (some of

read more